Cargando…

Oral Delivery of Novel Recombinant Lactobacillus Elicit High Protection against Staphylococcus aureus Pulmonary and Skin Infections

Staphylococcus aureus is a leading cause of nosocomial and community-associated infection worldwide; however, there is no licensed vaccine available. S. aureus initiates infection via the mucosa; therefore, a mucosal vaccine is likely to be a promising approach against S. aureus infection. Lactobaci...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Na, Liu, Bohui, Bao, Xuemei, Zhang, Haochi, Sheng, Shouxin, Liang, Yanchen, Pan, Haiting, Wang, Xiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473125/
https://www.ncbi.nlm.nih.gov/pubmed/34579221
http://dx.doi.org/10.3390/vaccines9090984